[42]. Kumar S， Matheny CJ， Hoffman SJ， Marquis RW， Schultz M， Liang X， et al. An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation. Bone. 2010;46：534–42.

    [43]. Wilder L， Gamse R， Seuwen K， Buhl T， Beerli R， Breitenstein W， et al. A novel calcium-sensing receptor antagonist leads to dose-dependent tran

    sient release of parathyroid hormone after oral administration to healthy volunteers- and initial prood-of-concept for a potential new class of anabolic osteoporosis therapeutics. J Bone Miner Res.2008;23(Suppl 1)：S49.

    [44]. Fitzpatrick LA ......